See-Spital Secures Bond Refinancing Through Long-Term Sale-and-Lease-Back Deal With Infracore

AEVIS VICTORIA SA ( (CH:AEVS) ) has provided an announcement.

See-Spital has agreed to sell the building and land of its Horgen site to hospital real estate specialist Infracore SA and lease it back under a long-term rental agreement, securing refinancing for a CHF 100 million bond maturing in July 2026. The transaction frees up tied capital for investments in medical services, technology and digitalization while shifting real estate responsibilities to Infracore, allowing See-Spital to focus on core clinical activities and ensuring the long-term use and development of the Horgen health campus.

For Infracore, the deal adds another major hospital property to its Swiss portfolio and aligns with its strategy of building stable, long-term healthcare infrastructure assets. Both partners highlight that the strengthened financial base and dedicated infrastructure expertise should support sustainable expansion of services at the site and provide greater security for patients, staff and the broader region.

The most recent analyst rating on (CH:AEVS) stock is a Buy with a CHF17.00 price target. To see the full list of analyst forecasts on AEVIS VICTORIA SA stock, see the CH:AEVS Stock Forecast page.

More about AEVIS VICTORIA SA

See-Spital is a Swiss foundation-run hospital providing modern medicine and comprehensive acute care services to around 130,000 regional inhabitants, including 24/7 emergency care, intensive care, internal medicine, surgery, women’s health with maternity, geriatrics, rehabilitation and extensive therapy offerings. Infracore AG is a Swiss real estate company focused on owning, developing and managing hospital and clinic buildings, with a portfolio of 47 properties across 19 locations in Switzerland, leased mainly under long-term contracts to hospital operators such as Swiss Medical Network.

Average Trading Volume: 2,605

Technical Sentiment Signal: Hold

Current Market Cap: CHF1.14B

See more insights into AEVS stock on TipRanks’ Stock Analysis page.